BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 117157
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.117157
Table 2 Baseline comparison table in large hepatic hemangioma group, mean ± SD/n (%)/median (interquartile rage)

Liver subcapsular (n = 63)
Liver parenchymal (n = 17)
t/Z/χ2
P value
Age (years)46.92 ± 10.76246.29 ± 11.22-0.2110.833
Sex0.0001.000
    Male14 (22.2)4 (23.5)
    Female49 (77.8)13 (76.5)
BMI24.44 ± 3.0724.68 ± 4.58-0.7310.803
Size (cm)7.20 ± 1.246.94 ± 1.180.7820.436
Location of main lesion1.3960.237
    Left lobe14 (22.2)1 (5.88)
    Right lobe49 (77.8)16 (94.12)
Number of lesions0.7200.698
    125 (39.7)7 (41.2)
    210 (15.9)4 (23.5)
    Multiple28 (44.4)6 (35.3)
Hepatitis B virus1 (1.59)0 (0)
Reasons for operation0.990
    Symptomatic5 (7.9)2 (11.8)
    Enlargement58 (92.1)15 (88.2)
Inflammatory
    WBC (109/L)5.26 ± 1.605.75 ± 1.61-1.1260.297
    Neutrophil (%)128.22 ± 15.58134.12 ± 12.65-1.4360.155
    Hb (g/L)51.40 (47.18-59.85)50.95 (46.08-61.18)-0.1120.911
Liver function
    TB (μmol/L)14.08 ± 13.4113.21 ± 6.100.2580.797
    ALT (U/L)12.00 (10.00-15.75)13.30 (11.00-16.75)-0.8070.420
    AST (U/L)15.00 (13.00-16.75)15.00 (12.88-19.00)-0.6050.545
    GGT (U/L)15.00 (13.00-19.50)25.50 (14.00-31.50)-1.4340.152
Coagulation
    PT (seconds)11.54 ± 0.5911.88 ± 1.16-1.6560.102
    D-D (μg/L)155.50 (133.25-214.50)183.00 (88.75-545.00)-0.9570.338
Renal function
    Cr (μmol/L)65.30 ± 11.2262.35 ± 14.420.9020.370
    BUN (mg/dL)4.81 ± 1.424.86 ± 1.49-0.1300.897


Write to the Help Desk